Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Sep 15;89(6):1140-1; author reply 1141-2.
doi: 10.1038/sj.bjc.6601176.

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

T Powles, J Shamash, D Berney, R T D Oliver
Comment

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

T Powles et al. Br J Cancer. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Berney DM, Shamash J, Gaffney J, Jordan S, Oliver RT (2002) DNA topoisomerase I and II expression in drug resistant germ cell tumours. Br J Cancer 87 (6): 624–629 - PMC - PubMed
    1. Bokemeyer C, Gerl A, Schoffski P, Harstrick A, Niederle N, Beyer J, Casper J, Schmoll HJ, Kanz L (1999) Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17 (2): 512–516 - PubMed
    1. Hinton S, Catalano P, Einhorn LH, Loehrer Sr PJ, Kuzel T, Vaughn D, Wilding G (2002) Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 20 (7): 1859–1863 - PubMed
    1. Kollmannsberger C, Rick O, Derigs HG, Schleucher N, Schoffski P, Beyer J, Schoch R, Sayer HG, Gerl A, Kuczyk M, Spott C, Kanz L, Bokemeyer C (2002a) Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol 20 (8): 2031–2037 - PubMed
    1. Kollmannsberger C, Rick O, Klaproth H, Kubin T, Sayer HG, Hentrich M, Welslau M, Mayer F, Kuczyk M, Spott C, Kanz L, Bokemeyer C (2002b) Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group. Br J Cancer 87 (7): 729–732 - PMC - PubMed

MeSH terms